Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.
about
Lipid composition and fluidity of the human immunodeficiency virus.Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.Factor VIII concentrate for hemophilia: comparison of two heat-treated products.A comparative evaluation of disinfection effect of exposures to ultra-violet light and direct current glow discharge on Candida Albicans colonies coated over elastomeric impression material: An in vitro studyImportance of collection tube during clinical studies of oseltamivir.Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.Human Immunodeficiency Virus (HIV).Evaluation of rubella immune status by three commercial enzyme-linked immunosorbent assays.Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation.Anti-HTLV-III positive laboratory reagents.Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods.Inactivation of Bombyx mori macula-like virus under physical conditions.Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages.Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.HIV-1 Exploits a Dynamic Multi-aminoacyl-tRNA Synthetase Complex To Enhance Viral Replication.Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems.HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.Prevention of transmission of HIV by organ and tissue transplantation. HIV testing protocol and a proposal for recommendations concerning donor selection.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus.Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.Heat treatment for endocrinological investigations on plasma positive for human immunodeficiency virus (HIV).Heat inactivation of specimens--AIDS.Rapid indirect enzyme linked immunosorbent assay (ELISA) for detecting antitoxoplasma IgG: comparison with dye test.Effect of heat treatment of potentially infected blood samples on therapeutic drug monitoring of selected drugs.The potential value of hyperthermia in the management of human immunodeficiency virus infection.Thermostability of human immunodeficiency virus (HIV-1) in a liquid matrix is far higher than that of an ecotropic murine leukemia virus.AIDS, hepatitis and hemophilia in the 1980s: memoirs from an insider.Heat-treated NHS factor VIII concentrate in the United Kingdom--a preliminary study.Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - Increased sensitivity resulting from reduced non-specific binding.Improving Pasteurization to Preserve the Biological Components of Donated Human Milk
P2860
Q34048036-E411EA97-8F7B-419E-B239-45767886E831Q34550838-99E6B700-D59D-46F4-BC5E-3663B10734DEQ34731218-A1E52D6E-0E8E-4B5E-B9FD-79F6A8E402E3Q34942248-9E695E58-5866-40C1-99CF-D278F167EF7BQ35759115-872E854C-C70D-45F9-B6EC-F652678C9442Q35897391-B8F40D81-2F80-4318-8E66-542A79936E30Q37045832-ED5BDECF-314E-4404-8E1E-0CC408BEE5F4Q37149432-2E832CBB-4446-4269-BAEC-737FE26ECE00Q37157165-32CB2934-F4D4-4A55-89A0-2417C1B96557Q37203717-021070B3-674F-4F08-976B-C0AF7BAAF693Q37206221-41852898-B94F-4D59-8CE0-8CE587A81A28Q38821720-924EFFB4-6EA2-43E9-A6EC-2489EC2C4B24Q39683481-3B9BB615-79FE-469B-A401-20DE0D8F1EAAQ39869534-CB522992-721F-4FBB-B4EF-2664D8B4DDFEQ40080869-A5DC7952-3A2E-40B6-A7EA-66798E742820Q40208864-20359741-714A-4240-AE66-848576FFA579Q40221887-9FDD8B74-AD7E-4C28-B604-B6E06C794CBDQ40761966-5AE74539-CADF-4BA7-8DCF-D8B07A8899EEQ40909941-1D7BDE54-5DBB-4AB3-AA6F-E9CCE7A1C19BQ40942917-98E987F7-7C15-4BEE-A049-540E01B1F9E2Q41406431-C30C2620-C64E-4E5A-B6A6-13EC39D3EAFBQ41522139-DC658DB4-777E-41F7-BB84-4EF31E2BDF49Q42005858-AFA1A8E7-59E9-4520-A448-F169F654174EQ42556350-05D5CB10-0AC6-4CA9-A28B-E4F634840E9AQ42842187-3F384699-1A25-4B62-AA61-FBD58A15E697Q43888534-97A09D30-A912-4758-92D0-A41EE2E7C425Q44303832-0806C634-ACCE-4837-AA85-1A7FE1B66A03Q45846803-9DCE4032-BEBD-4935-9353-C4E8F250DC2BQ45869176-5F105606-FE7B-4DBA-8D61-07E191C0F7F5Q45886493-66BA99DD-FE7B-4F76-9841-FB85F2F1AE36Q47107114-C2849FA6-BDD9-47E7-9EF9-17F099698033Q57816928-59D95D1E-5BBF-4946-A166-184895DB1BD7
P2860
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@en
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@nl
type
label
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@en
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@nl
prefLabel
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@en
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@nl
P50
P1433
P1476
Inactivation of lymphadenopath ...... a rays, and ultraviolet light.
@en
P2093
P304
P356
10.1016/S0140-6736(85)92026-4
P407
P577
1985-01-01T00:00:00Z